Drug profile · INN
pretomanid
DOVPRELA (PREVIOUSLY PRETOMANID FGK)
pretomanid (DOVPRELA (PREVIOUSLY PRETOMANID FGK)) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Drug details — pretomanid
- US status
- approved
- Class
- Antiinfectives for systemic use (J04)
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
pretomanid (DOVPRELA (PREVIOUSLY PRETOMANID FGK)) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pretomanid?
pretomanid (DOVPRELA (PREVIOUSLY PRETOMANID FGK)) is a unknown. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pretomanid?
DOVPRELA (PREVIOUSLY PRETOMANID FGK) is a marketed brand name for pretomanid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pretomanid?
pretomanid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.